Mapol Inc. is pleased to be a Silver Sponsor for the upcoming CAPT ACTP Annual Conference held November 17-19, 2013 in Toronto.  For more information, please visit: http://www.capt-actp.com/conference/

Benefits Canada featured a supplement on Mandatory Generic Substitution Plans.  Download the PDF below.

We are pleased to announce the dates for this year's Private Payer Pulse® Education & Training Seminars: 'Emerging Trends and Issues in Private Payer Drug Plans'. The Toronto session will be held Tuesday, November 5 at the Hilton Garden Inn Toronto/Brampton (8:00 a.m. - 3:30 p.m.) and the Montréal session will be held Thursday, November 7 at the Hilton Montréal Bonaventure Hotel (8:00 a.m. - 4:00 p.m.).

Toronto Registration: Click Here to Register

Montréal Registration: Click Here to Register

These seminars are developed exclusively for brand pharmaceutical manufacturers that have an interest in understanding and engaging private payer decision makers in Canada. Building upon last year's session, our agenda this year will focus on the emerging trends and issues within private payer drug plans.

This includes:

• Barbara Martinez (Great-West Life): 'Trends and Plan Designs, Where is the market going?'
• Dave Madill (Pharmacy Technologies Limited): 'Employer Coalitions, Lessons Learned'
• Jean-Yves Julien (Industry Consultant): 'Loyalty/Co-pay Cards - a perspective from Québec'
• Fred Holmes (Industry Consultant):'Understanding and Interacting with Benefits Consultants'
• Mapol Inc: 'Industry Issues for Consideration by Panelists'
• Benefits Advisors Panel Discussion with audience Q&A:
• Dave Madill (Pharmacy Technologies Limited), Benefits Consultant (TBA), Third Party Administrator (TBA), Paula Allen (Morneau Shepell) - Toronto Only and Cathy Fuchs (White Willow Benefit Consultants) - Toronto Only
• Mapol Inc: 'Trends and Issues Update for Private Payer Market'

Note: If your company is registering 3 or more people between both Toronto and Montréal events, please contact Corinne Razem at (905) 393-3597 or crazem@mapol.ca for a group discount code.

We look forward to seeing you there!

Read the interview by clicking here.

Patient Assistance Programs – Demystified

By Johnny Ma and Gordon Polk, Benefits and Pensions Monitor (April 2013)

Pharmaceutical products represent a significant cost component of an employer’s health benefits plan. For plan sponsors, that may not be a bad thing, particularly if plan members can remain on the job and perform effectively. However, plan sponsors often want to ensure that good value is being received for the benefits dollars being spent. One of the less visible value-adds that come with some prescribed drugs is the support from patient assistance programs.

Read Full Article